DSIP (Delta Sleep-Inducing Peptide)

DSIP in the Published Literature

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

PubMed indexes roughly 519 DSIP records, spanning from the 1977 isolation to the present. Despite that volume the central claim remains unresolved, and the field's own 2006 review describes it as a riddle. Publication count here reflects sustained interest rather than accumulated confirmation.

Key facts

Indexed PubMed records
~519
First publication
March 1977 (PNAS)
Sequence paper
1978, Pflügers Arch
Key review
Kovalzon 2006, J Neurochem
Review's verdict
'A still unresolved riddle'
Registered clinical trials
None established
Regulatory review
None

A large literature and a small conclusion

519 records is substantially more than Selank's 135 or Semax's 231, and comparable to well-studied research compounds. Yet the question that prompted the first paper, whether this peptide has a role in sleep, has no settled answer. That combination is the most useful thing to know about the literature before reading any individual paper in it.

Why volume is not weight

Papers accumulate for many reasons. A tractable question with a clear answer generates a burst of work and then stops. An interesting question that resists resolution generates papers indefinitely, each a further attempt rather than a further confirmation. DSIP's publication profile looks much more like the second pattern, and Kovalzon's 2006 title states the field's assessment explicitly.

Research material referenced

DSIP 5mg, third-party HPLC tested

Buy DSIP · £13.95

The shape of the work

The literature spans the original isolation and sequencing, a large body of animal work examining sleep and other reported activities, and reviews periodically taking stock. What it does not contain is the gene, precursor and receptor work that would have converted the hypothesis into biology, and it contains no established programme of registered clinical trials.

The 1970s context

DSIP emerged during a period of intense interest in humoral sleep factors: the idea that sleep is driven by circulating substances that accumulate during waking. Several candidates were proposed in that era and most did not survive as sleep factors, though some found other roles. Reading DSIP as part of that cohort, rather than in isolation, makes its trajectory less surprising.

How to search it

PubMed indexes the field under 'delta sleep-inducing peptide'; the INN emideltide surfaces regulatory records the abbreviation misses. Filtering by publication type separates reviews from primary research, and checking the model organism is the fastest way to establish what kind of evidence a paper offers. For DSIP specifically, checking whether a paper administers the peptide or merely measures it is the most informative single question.

Frequently asked questions

Are there clinical trials of DSIP?

No established programme of registered interventional trials, and no regulator has reviewed it.

Which paper should I read first?

Kovalzon's 2006 review in the Journal of Neurochemistry, PMID 16539679. It is the clearest available account of what has and has not been established.

Does 519 papers mean DSIP is well established?

No. Publication volume reflects sustained interest in an unresolved question rather than accumulated confirmation of an answer.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More DSIP (Delta Sleep-Inducing Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.